Sanofi SNY announced that the FDA has granted a Fast Track designation to two combination vaccine candidates to prevent ...

The candidates merge two existing vaccines that have demonstrated favourable tolerability through randomised controlled ...

Here’s what to know about the 2024-2025 vaccines — what’s available, how the updated versions are tested, how well each protects you, side effects and other safety information, the best time to get ...

The menstrual irregularities experienced by unvaccinated and unexposed women were consistent with those experienced by the ...

Novavax is working with the FDA to explore a pathway for accelerated approval of the COVID-19-flu combination and standalone ...

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the ...

The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...

TAU’s groundbreaking project has received competitive research grants from the Israel Innovation Authority and Merck under ...

A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution ...

Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US First non-mRNA combination vaccine candidates that include two already licensed ...

SARS-CoV-2 spike protein lingers in brain tissues for years. While vaccines cut accumulation by 50%, risks remain. Read more.

Researchers find that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis, driving neuroinflammation, ...